E. Lopez-Rangel and MI Van Allen. Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype. Birth Defects Res A Clin Mol Teratol. 2005 Nov; 73(11):919-23.
E. Lopez-Rangel and MES Lewis. Loud and clear evidence for gene silencing by epigenetic mechanisms in autism spectrum and related neurodevelopmental disorders. Clinical Genetics 2006 Jan; 69(1):21-2.
M. Khashu, H. Osiovich, D. Rudman D, E. Lopez-Rangel (misprinted as E. Lopez) and S. Langlois. The tale of a Belly Button: Rieger Syndrome. Clin Pediatr (Phila). 2006 Jun;45(5):453-455.
E. Lopez-Rangel. Overlapping clinical phenotypes: the road to identifying dysmorphology signalling pathways and their associated risks. Clin Genet 2007: 71: 43–45.
E. Lopez-Rangel. The neoplastic risk in children with Noonan syndrome and Costello syndrome. Clin Genet 2007: 71: 43–45.
E Lopez-Rangel E, ECR Mickelson ECR, SME Lewis. The value of a genetic diagnosis for individuals with intellectual disabilities: Optimizing healthcare and function across the lifespan. British J of Dev Dis. 2008:54 (107): 69-82.
Qiao Y, Tyson C, Hrynchak M, Lopez-Rangel E, Hildebrand J, Martell S, Fawcett C, Kasmara L, Calli K, Harvard C, Liu X, Holden J, Lewis S, Rajcan-Separovic E.Clinical application of 2.7M Cytogenetics array for CNV detection in subjects with idiopathic autism and/or intellectual disability. Clin Genet. 2013 Feb;83(2):145-154. doi: 10.1111/j.1399-0004.2012.01860.x. Epub 2012 Apr 9.